WS #13344

19:12→19:41 UTC

From 499 msgs · 6 key-dev

AstraZeneca falls ~8% on reports of exploring $400B merger with Bristol Myers Squibb, dragging UK pharma and FTSE.

AstraZeneca-Bristol Myers merger talks

AstraZeneca falls ~8% on reports of exploring $400B merger with Bristol Myers Squibb, dragging UK pharma and FTSE.